ALDH18A1 and endometrial cancer: Additionally, the isoform ALDH18A1 was identified as the most abundant ALDH isoform in the proteomic profile of both endometrial cancer cell lines and one of the most down-regulated proteins upon DEAB treatment, this isoform being considered the most inhibited.